{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:08:49Z","timestamp":1792840129025,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T00:00:00Z","timestamp":1678838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.yjmcc.2023.03.002","type":"journal-article","created":{"date-parts":[[2023,3,12]],"date-time":"2023-03-12T10:59:39Z","timestamp":1678618779000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Development of direct cardiac reprogramming for clinical applications"],"prefix":"10.1016","volume":"178","author":[{"given":"Yu","family":"Yamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taketaro","family":"Sadahiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Ieda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2023.03.002_bb0005","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jchf.2021.09.004","article-title":"A systematic review and network meta-analysis of pharmacological treatment of heart failure with reduced ejection fraction","volume":"10","author":"Tromp","year":"2022","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0015","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/eurheartj\/ehaa1012","article-title":"Heart failure drug treatment: the fantastic four","volume":"42","author":"Bauersachs","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0020","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart disease and stroke statistics - 2022 update: a report from the American heart association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0025","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cell.2010.07.002","article-title":"Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors","volume":"142","author":"Ieda","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.semcdb.2021.06.019","article-title":"In vivo reprogramming as a new approach to cardiac regenerative therapy","volume":"122","author":"Sadahiro","year":"2022","journal-title":"Semin Cell Dev. Biol."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0035","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.semcdb.2021.07.010","article-title":"Direct cardiac reprogramming comes of age: recent advance and remaining challenges","volume":"122","author":"Xie","year":"2022","journal-title":"Semin Cell Dev. Biol."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0040","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2015-000298","article-title":"MRI and serum high-sensitivity C reactive protein predict long-term mortality in non-ischaemic cardiomyopathy","volume":"2","author":"Sadahiro","year":"2015","journal-title":"Open Heart"},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0045","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/eurheartj\/ehy713","article-title":"Prevalence and prognosis of ischaemic and non-ischaemic myocardial fibrosis in older adults","volume":"40","author":"Shanbhag","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0050","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/jama.2013.1363","article-title":"Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy","volume":"309","author":"Gulati","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0055","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nature11044","article-title":"In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes","volume":"485","author":"Qian","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0060","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature11139","article-title":"Heart repair by reprogramming non-myocytes with cardiac transcription factors","volume":"485","author":"Song","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0065","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1161\/CIRCRESAHA.112.271148","article-title":"Induction of cardiomyocyte-like cells in infarct hearts by gene transfer of Gata4, Mef2c, and Tbx5","volume":"111","author":"Inagawa","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0070","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1161\/CIRCRESAHA.112.269035","article-title":"MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes","volume":"110","author":"Jayawardena","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0075","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/CIRCRESAHA.116.304510","article-title":"MicroRNA induced cardiac reprogramming in vivo: evidence for mature cardiac myocytes and improved cardiac function","volume":"116","author":"Jayawardena","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0080","first-page":"103","article-title":"Direct in vivo reprogramming with Sendai virus vectors improves cardiac function after myocardial infarction","volume":"91","author":"Miyamoto","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0085","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0090","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/CIRCRESAHA.116.305547","article-title":"Stoichiometry of Gata4, Mef2c, and Tbx5 influences the efficiency and quality of induced cardiac myocyte reprogramming","volume":"116","author":"Wang","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0095","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/cvr\/cvv223","article-title":"In vivo cardiac reprogramming using an optimal single polycistronic construct","volume":"108","author":"Ma","year":"2015","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0100","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s12265-012-9412-5","article-title":"Direct reprogramming of mouse fibroblasts into cardiac myocytes","volume":"6","author":"Inagawa","year":"2013","journal-title":"J. Cardiovasc Transl. Res."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0105","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1161\/CIRCULATIONAHA.116.024692","article-title":"Chemical enhancement of in vitro and in vivo direct cardiac reprogramming","volume":"135","author":"Mohamed","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0110","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.005652","article-title":"In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor","volume":"1","author":"Mathison","year":"2012","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0115","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.jtcvs.2014.03.033","article-title":"\u201cTriplet\u201d polycistronic vectors encoding Gata4, Mef2c, and Tbx5 enhances postinfarct ventricular functional improvement compared with singlet vectors","volume":"148","author":"Mathison","year":"2014","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0120","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bbrc.2021.04.121","article-title":"Direct reprogramming with Sendai virus vectors repaired infarct hearts at the chronic stage","volume":"560","author":"Isomi","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0125","doi-asserted-by":"crossref","first-page":"11319","DOI":"10.1038\/srep11319","article-title":"A cost-effective and efficient reprogramming platform for large-scale production of integration-free human induced pluripotent stem cells in chemically defined culture","volume":"5","author":"Beers","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0130","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0135","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41576-019-0205-4","article-title":"Engineering adeno-associated virus vectors for gene therapy","volume":"21","author":"Li","year":"2020","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0140","doi-asserted-by":"crossref","first-page":"5918","DOI":"10.1021\/acsomega.8b00904","article-title":"Chimeric adeno-associated virus-mediated cardiovascular reprogramming for ischemic heart disease","volume":"3","author":"Yoo","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0145","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1152\/physiolgenomics.00032.2022","article-title":"Distribution of cardiomyocyte-selective adeno-associated virus serotype 9 vectors in swine following intracoronary and intravenous infusion","volume":"54","author":"Li","year":"2022","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0150","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/hum.2018.015","article-title":"Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an adeno-associated virus vector expressing human SMN","volume":"29","author":"Hinderer","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0155","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ymthe.2020.12.007","article-title":"Current clinical applications of in vivo gene therapy with AAVs","volume":"29","author":"Mendell","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0160","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.biomaterials.2018.11.034","article-title":"Efficient in vivo direct conversion of fibroblasts into cardiomyocytes using a nanoparticle-based gene carrier","volume":"192","author":"Chang","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0165","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.addr.2008.03.016","article-title":"Gold nanoparticles in delivery applications","volume":"60","author":"Ghosh","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0170","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1016\/j.ymthe.2021.07.014","article-title":"Direct reprogramming induces vascular regeneration post muscle ischemic injury","volume":"29","author":"Kaur","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0175","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/CIRCULATIONAHA.121.056135","article-title":"Myocarditis with COVID-19 mRNA vaccines","volume":"144","author":"Bozkurt","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0180","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/cr.2015.99","article-title":"Direct reprogramming of mouse fibroblasts into cardiomyocytes with chemical cocktails","volume":"25","author":"Fu","year":"2015","journal-title":"Cell Res."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0185","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/s41422-018-0036-4","article-title":"Chemical-induced cardiac reprogramming in vivo","volume":"28","author":"Huang","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0190","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1126\/science.aaf1502","article-title":"Conversion of human fibroblasts into functional cardiomyocytes by small molecules","volume":"352","author":"Cao","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0195","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1161\/CIRCULATIONAHA.120.052799","article-title":"Overexpression of Gata4, Mef2c, and Tbx5 generates induced cardiomyocytes via direct reprogramming and rare fusion in the heart","volume":"143","author":"Isomi","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0200","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/CIRCULATIONAHA.121.058655","article-title":"Direct reprogramming improves cardiac function and reverses fibrosis in chronic myocardial infarction","volume":"147","author":"Tani","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0205","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1161\/CIRCULATIONAHA.117.029753","article-title":"Honoring 50 years of clinical heart transplantation in circulation: in-depth state-of-the-art review","volume":"137","author":"Stehlik","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0210","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1172\/JCI98215","article-title":"Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart","volume":"128","author":"Fu","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0215","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrcardio.2017.57","article-title":"Redefining the identity of cardiac fibroblasts","volume":"14","author":"Tallquist","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0220","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.yjmcc.2010.09.008","article-title":"Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats","volume":"49","author":"Fernandes","year":"2010","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0225","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/1074248413520344","article-title":"Electrical integration of human embryonic stem cell-derived cardiomyocytes in a guinea pig chronic infarct model","volume":"19","author":"Shiba","year":"2014","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0230","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10137","article-title":"Role of YAP\/TAZ in mechanotransduction","volume":"474","author":"Dupont","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0235","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.stemcr.2020.07.022","article-title":"Soft matrix promotes cardiac reprogramming via inhibition of YAP\/TAZ and suppression of fibroblast signatures","volume":"15","author":"Kurotsu","year":"2020","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101122","article-title":"A biomimetic hydrogel culture system to facilitate cardiac reprogramming","volume":"3","author":"Kurotsu","year":"2022","journal-title":"STAR Protoc."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0245","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/CIRCRESAHA.113.301720","article-title":"Remodeling of the mononuclear phagocyte network underlies chronic inflammation and disease progression in heart failure: critical importance of the cardiosplenic axis","volume":"114","author":"Ismahil","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0250","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1161\/01.RES.0000163017.13772.3a","article-title":"CCL2\/monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts","volume":"96","author":"Dewald","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0255","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.yjmcc.2017.11.012","article-title":"Resident fibroblast expansion during cardiac growth and remodeling","volume":"114","author":"Ivey","year":"2018","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0260","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/s41586-021-03674-1","article-title":"A transcriptional switch governs fibroblast activation in heart disease","volume":"595","author":"Alexanian","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0265","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.addr.2019.05.011","article-title":"Cardiac fibrosis - a short review of causes and therapeutic strategies","volume":"146","author":"Hinderer","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0270","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41586-022-04817-8","article-title":"Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy","volume":"608","author":"Chaffin","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0275","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41556-019-0446-7","article-title":"Single-cell reconstruction of the adult human heart during heart failure and recovery reveals the cellular landscape underlying cardiac function","volume":"22","author":"Wang","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0280","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s44161-022-00028-6","article-title":"Single-cell transcriptomics reveals cell-type-specific diversification in human heart failure","volume":"1","author":"Koenig","year":"2022","journal-title":"Nat. Cardiovasc Res."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0285","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.cmet.2017.03.016","article-title":"Using DNA methylation profiling to evaluate biological age and longevity interventions","volume":"25","author":"Petkovich","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0290","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.stem.2015.09.001","article-title":"Directly reprogrammed human neurons retain aging-associated transcriptomic signatures and reveal age-related nucleocytoplasmic defects","volume":"17","author":"Mertens","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0295","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jacbts.2020.11.017","article-title":"Intramyocardial transplantation of human iPS cell-derived cardiac spheroids improves cardiac function in heart failure animals","volume":"6","author":"Kawaguchi","year":"2021","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0300","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nature19815","article-title":"Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts","volume":"538","author":"Shiba","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0305","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nbt.4162","article-title":"Human embryonic stem cell-derived cardiomyocytes restore function in infarcted hearts of non-human primates","volume":"36","author":"Liu","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0310","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.stemcr.2021.08.005","article-title":"Pharmacologic therapy for engraftment arrhythmia induced by transplantation of human cardiomyocytes","volume":"16","author":"Nakamura","year":"2021","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0315","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.stemcr.2013.07.005","article-title":"Direct reprogramming of human fibroblasts toward a cardiomyocyte-like state","volume":"1","author":"Fu","year":"2013","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0320","doi-asserted-by":"crossref","first-page":"12667","DOI":"10.1073\/pnas.1304053110","article-title":"Induction of human cardiomyocyte-like cells from fibroblasts by defined factors","volume":"110","author":"Wada","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0325","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1073\/pnas.1301019110","article-title":"Reprogramming of human fibroblasts toward a cardiac fate","volume":"110","author":"Nam","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0330","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/s41467-019-08626-y","article-title":"Role of cyclooxygenase-2-mediated prostaglandin E2-prostaglandin E receptor 4 signaling in cardiac reprogramming","volume":"10","author":"Muraoka","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0335","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.15252\/embj.201387605","article-title":"MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures","volume":"33","author":"Muraoka","year":"2014","journal-title":"EMBO J."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0340","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s13238-017-0402-x","article-title":"Molecular barriers to direct cardiac reprogramming","volume":"8","author":"Vaseghi","year":"2017","journal-title":"Protein Cell"},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0345","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.stem.2019.05.020","article-title":"Single-cell transcriptomic analyses of cell fate transitions during human cardiac reprogramming","volume":"25","author":"Zhou","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0350","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.stem.2019.06.012","article-title":"Context-specific transcription factor functions regulate epigenomic and transcriptional dynamics during cardiac reprogramming","volume":"25","author":"Stone","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0355","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.stem.2019.03.022","article-title":"Cardiac reprogramming factors synergistically activate genome-wide cardiogenic stage-specific enhancers","volume":"25","author":"Hashimoto","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0360","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41556-021-00668-z","article-title":"The histone reader PHF7 cooperates with the SWI\/SNF complex at cardiac super enhancers to promote direct reprogramming","volume":"23","author":"Garry","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0365","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1161\/CIRCULATIONAHA.122.059713","article-title":"TBX20 improves contractility and mitochondrial function during direct human cardiac reprogramming","volume":"146","author":"Tang","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0370","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022659","article-title":"Hippo pathway effector Tead1 induces cardiac fibroblast to cardiomyocyte reprogramming","volume":"10","author":"Singh","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.yjmcc.2023.03.002_bb0375","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay7856","article-title":"Down-regulation of Beclin1 promotes direct cardiac reprogramming","volume":"12","author":"Wang","year":"2020","journal-title":"Sci. Transl. Med."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282823000354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282823000354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T20:37:39Z","timestamp":1758314259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282823000354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":75,"alternative-id":["S0022282823000354"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2023.03.002","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of direct cardiac reprogramming for clinical applications","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2023.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}